Pigmented Nail Lesions: When to Observe, When to Biopsy, When to Widely Excise, and When to Amputate?

J Hand Surg Am · Oct 2022 · Review

Das De S, Tan KB, Ho SJE, Athanasian EA, Puhaindran ME

Department of Hand & Reconstructive Microsurgery, National University Hospital, Singapore

Hand & Upper Extremity

SUMMARY — THE REDUCTIONSubungual melanoma diagnosis requires clinical assessment and often biopsy; management decisions should integrate latest evidence rather than adapt cutaneous melanoma guidelines.
Abstract, as published

Pigmented nail lesions are challenging problems. The differential diagnosis is broad and ranges from common self-limiting conditions, such as subungual hematoma and infection, to potentially fatal conditions, such as subungual melanoma. Clinical assessment and adjuncts, such as dermoscopy and imaging, are usually insufficient to establish a diagnosis, and a nail bed biopsy is often required. However, this is not an innocuous procedure and may result in permanent nail deformity. In addition, subjecting every patient with nail pigmentation to a biopsy will result in an unacceptably high rate of negative test results. Furthermore, histopathologic diagnosis of subungual melanoma remains challenging for several reasons. Once the diagnosis of subungual melanoma is established, the definitive treatment is controversial because the existing guidelines have largely been adapted from those for cutaneous melanoma. This review presents an approach to the diagnosis and management of pigmented subungual lesions and subungual melanoma, in particular, on the basis of the latest available evidence.

Featured in the 2026-07-16 issue.

← Standardized Volar Silicone PIP Arthroplasty: Bilateral Proxi…Management of the Spastic Elbow Deformity in Adult Patients W… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.